Infographic details who gave what to whom as all segments of the US healthcare industry gear up for the presidential election cycle.

In year two, Humira biosimilar uptake – or the lack thereof – continues to build the case for policy reform to incentivize use of cheaper biologics in the outpatient setting.

Our infographic breaks down the biggest contributors, recipients and legislative targets.